StockClub

COLL

COLLCollegium Pharmaceutical, Inc.$ --
Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical, Inc.

COLL

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
205M USD
YoY +12.9%
Operating Income
59M USD
YoY +55.4%
Net Income
17M USD
YoY +35.3%
EPS
0.54$
YoY +38.5%

Revenue

$780.6M
FY2024 Q1$144.9M
$144.9M
Q1
FY2024 Q2$290.2M
$290.2M
Q2
FY2024 Q3$449.5M
$449.5M
Q3
FY2024 Q4$631.4M
$631.4M
Q4
FY2025 Q1$177.8M
$177.8M
Q1
FY2025 Q2$365.8M
$365.8M
Q2
FY2025 Q3$575.1M
$575.1M
Q3
FY2025 Q4$780.6M
$780.6M
Q4
Actual
+$149.1M (+23.6%)

Net Income

$62.9M
FY2024 Q1$27.7M
$27.7M
Q1
FY2024 Q2$47.3M
$47.3M
Q2
FY2024 Q3$56.7M
$56.7M
Q3
FY2024 Q4$69.2M
$69.2M
Q4
FY2025 Q1$2.4M
$2.4M
Q1
FY2025 Q2$14.4M
$14.4M
Q2
FY2025 Q3$45.9M
$45.9M
Q3
FY2025 Q4$62.9M
$62.9M
Q4
Actual
$-6.3M (-9.1%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:$310M
Est:$311.2M
FY2020MISS
$310M
FY2021MISS
Actual:$276.9M
Est:$332.4M
FY2021MISS
$276.9M
FY2022BEAT
Actual:$463.9M
Est:$459.5M
FY2022BEAT
$463.9M
FY2023MISS
Actual:$566.8M
Est:$576.7M
FY2023MISS
$566.8M
FY2024BEAT
Actual:$631.4M
Est:$629.3M
FY2024BEAT
$631.4M
FY2025MISS
Actual:$780.6M
Est:$781.5M
FY2025MISS
$780.6M

Analyst Estimates